clinicaltrials.gov· Liu Qing · ClinicalTrials.gov·2026-10-18 14:40· 5 hours agoScore23Safety, Tolerability, and Pharmacodynamic Exploration of Orelabrutinib in Patients With Amyotrophic Lateral Sclerosis (ALS)Source: clinicaltrials.gov#Clinical readout#Neuroscience#Rare disease